The early bird rate for the World Drug Safety Congress Europe is coming to an today, Friday June 22nd- register before then with the promotional code BL22 to save. You can call Sabrina on + 44 (0) 207 608 7055 or register online.
In a previous blog post we invited you to download Dr Vicki Edwards’ presentation on European Pharmacovigilance Legislation as a key update on how high level pharma executives are considering the EU Commission pharmacovigilance package. If you found that helpful remember that was from our 2011 event and much has changed.
At World Drug Safety Europe 2012 we are happy to announce that we have a whole morning dedicated to this topic! Check out the agenda now for the full 2 days including this EU legislation update which will include:
In depth review of the new European Pharmacovigilance legislation
Dr Ennis Lee, Vice President, QPPV, Johnson & Johnson
Implications for integration of the new EU legislation for pharma
Dr Omer De Mol, VP, PhV and Medical Information, Genzyme
Dr Astrid Herpers, EU-QPPV, Boehringer-Ingelheim
Dr Vicki Edwards, Senior Director, EU PhV, Abbott
Katrien Soleme, Head of Pharmacovigilance QA, UCB
Legislative requirements for the Pharmacovigilance system with focus on the Pharmacovigilance System Master File
Dr Ralph Nies, Vice President, EU-QPPV, Astellas
The new PSUR: key amendments following the EU Pharmacovigilance legislation changes
Dr Jean-Marie Heim, Director of Safety Assessment, BMS
Implementation of DSURs in Europe
Dr Barbara de Bernardi, Deputy EU QPPV, Pfizer
Expectations of Health Authorities from the strengthening of the QPPV role
Dr Ute Hoeffner, EU QPPV, Novartis
Remember to register before the end of the day with the promotional code BL22 to save.